HONG KONG – Leading Chinese vaccine maker Sinovac Biotech Ltd. resorted to the Hong Kong courts to fight off an attempted "coup" by a minority shareholder – an attempt that involved presenting allegedly fake documents filed in Hong Kong that suggested top management at Sinovac Biotech's holding company had resigned.
HONG KONG – Leading Chinese vaccine maker Sinovac Biotech Ltd. resorted to the Hong Kong courts to fight off an attempted "coup" by a minority shareholder – an attempt that involved presenting allegedly fake documents filed in Hong Kong that suggested top management at Sinovac Biotech's holding company had resigned.
HONG KONG – Scandals continue to cast a shadow on China's vaccine industry, with Changchun Changsheng Life Sciences Ltd. recently handed a hefty fine totaling ¥9.1 billion (US$1.3 billion). Meanwhile another vaccine maker, Sinovac Biotech Ltd., has been hobbled by company infighting, which has forced it to suspend production of vaccines for hepatitis A and seasonal flu, markets for which it supplied 18 percent and 12.7 percent, respectively, of vaccine production in China last year.
HONG KONG – Scandals continue to cast a shadow on China's vaccine industry, with Changchun Changsheng Life Sciences Ltd. recently handed a hefty fine totaling ¥9.1 billion (US$1.3 billion). Meanwhile another vaccine maker, Sinovac Biotech Ltd., has been hobbled by company infighting, which has forced it to suspend production of vaccines for hepatitis A and seasonal flu, markets for which it supplied 18 percent and 12.7 percent, respectively, of vaccine production in China last year.
HONG KONG – Chinese biotech firm Origimed Co. Ltd., of Shanghai, is taking part in building China's first cancer big data platform with two oncology organizations to gather genetic data of the Chinese population. That will give doctors more precise information to diagnose cancer and customize treatment.
HONG KONG – Chinese biotech firm Origimed Co. Ltd., of Shanghai, is taking part in building China's first cancer big data platform with two oncology organizations to gather genetic data of the Chinese population. That will give doctors more precise information to diagnose cancer and customize treatment.
